NDC 21586-031-01 - CLAFORAN

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
21586-031
Requested NDC
21586-031-01
Package NDCs from labels
21586-031-01, 21586-031-02
Manufacturer
SteriMax Inc. | Qilu Antibiotics Pharmaceutical Co., Ltd.
Effective date
2026-08-14
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
CLAFORAN - SteriMax Inc. | Qilu Antibiotics Pharmaceutical Co., Ltd.SteriMax Inc. | Qilu Antibiotics Pharmaceutical Co., Ltd.2026-08-14HUMAN PRESCRIPTION DRUG LABEL

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CLAFORANCEFOTAXIMESteriMax Inc.434fb630-c8d6-4583-b3ee-8e4ba6552c3d2026-08-14Warnings, Adverse reactionsExact identifier
application number: NDA050547
ndc (package): 21586-031-02
ndc (package): 21586-031-01
ndc (product): 21586-031
ndc11 (package): 21586003101
rxcui: 1656313
rxcui: 1656316
spl id: f03f3e64-fa62-4c69-a71e-086c58fc846f
spl set id: 434fb630-c8d6-4583-b3ee-8e4ba6552c3d
unii: 258J72S7TZ
CefotaximeCEFOTAXIME INJECTIONSteriMax Inc.8efe3bd0-c43a-2bd6-e053-2a95a90a92fa2026-06-15Exact identifier
rxcui: 1656313
unii: 258J72S7TZ
CefotaximeCEFOTAXIMEHikma Pharmaceuticals USA Inc.ed23b6bc-32c7-4c50-a53d-313ae78e56232024-04-11Warnings, Adverse reactionsExact identifier
rxcui: 1656313
unii: 258J72S7TZ
CefotaximeCEFOTAXIMEHikma Pharmaceuticals USA Inc.ef1a6dc6-bc3d-4f09-8f92-7ff328f565612024-04-11Warnings, Adverse reactionsExact identifier
unii: 258J72S7TZ

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.